Results 181 to 190 of about 5,305,995 (318)
Use of Chia by-Products Obtained from the Extraction of Seeds Oil for the Development of New Biodegradable Films for the Agri-Food Industry [PDF]
, 2021 Nuria Muñoz-Tébar +3 more
openalex +1 more source
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Molecular Oncology, EarlyView.Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
Psychological Resources and New Product Development Team Adaptability: A Moderated Mediation Model. [PDF]
Small Group ResMarques DL +3 more
europepmc +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
Molecular Oncology, EarlyView.CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Eyes on new product development. [PDF]
J Ocul Pharmacol Ther, 2013 Novack GD.
europepmc +2 more sources
Vegetable Waste in the Retail Sector: Evaluation and Possibilities for Use in New Product Development. [PDF]
FoodsChagas EGLD +5 more
europepmc +1 more source
, 2017 [EN] Product development has been approached by linear methods that apply to any design problem without concern of ambient variables. In this approach, we will find a new matrix method that can deliver a basic path in which the designer can begin his journey, but adaptable to accept ambient variables.
openaire +2 more sources
Organising and managing the fuzzy front end of new product development [PDF]
new product ...
Aken van, J.E.
core
Molecular Oncology, EarlyView.Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source